| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |